Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS: FRTX · Delayed Price · USD
0.950
+0.040 (4.39%)
Jul 2, 2024, 3:59 PM EDT - Market closed
Fresh Tracks Therapeutics Market Cap
Fresh Tracks Therapeutics has a market cap or net worth of $5.67 million as of July 2, 2024. Its market cap has increased by 20.74% in one year.
Market Cap
5.67M
Enterprise Value
-5.19M
1-Year Change
20.74%
Ranking
n/a
Category
Stock Price
$0.95
Market Cap Chart
Since December 1, 1998, Fresh Tracks Therapeutics's market cap has decreased from $248.20M to $5.67M, a decrease of -97.71%. That is a compound annual growth rate of -13.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2023 | 4.70M | 4.44% |
| Dec 30, 2022 | 4.50M | -82.89% |
| Dec 31, 2021 | 26.30M | -37.08% |
| Dec 31, 2020 | 41.80M | 257.26% |
| Dec 31, 2019 | 11.70M | -54.47% |
| Dec 31, 2018 | 25.70M | 11.26% |
| Dec 29, 2017 | 23.10M | -9.06% |
| Dec 30, 2016 | 25.40M | -32.27% |
| Dec 31, 2015 | 37.50M | -60.44% |
| Dec 31, 2014 | 94.80M | -7.42% |
| Dec 31, 2013 | 102.40M | -59.15% |
| Dec 31, 2012 | 250.70M | -20.91% |
| Dec 30, 2011 | 317.00M | 119.07% |
| Dec 31, 2010 | 144.70M | -15.13% |
| Dec 31, 2009 | 170.50M | 199.65% |
| Dec 31, 2008 | 56.90M | -65.85% |
| Dec 31, 2007 | 166.60M | -33.76% |
| Dec 29, 2006 | 251.50M | 112.06% |
| Dec 30, 2005 | 118.60M | 7.43% |
| Dec 31, 2004 | 110.40M | 11.74% |
| Dec 31, 2003 | 98.80M | 41.75% |
| Dec 31, 2002 | 69.70M | -71.60% |
| Dec 31, 2001 | 245.40M | -33.69% |
| Dec 29, 2000 | 370.10M | -23.69% |
| Dec 31, 1999 | 485.00M | 116.04% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |